MITRAGYNA SPECIOSA-INDUCED HEPATOTOXICITY-TREATED EFFECTIVELY BY PIPER BETLE: SCOPE AS A FUTURE ANTIDOTE
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i3.22958Keywords:
Mitragyna speciosa, Piper betle, Liver injury, Methanol extract, Microvesicular steatosis, FibrosisAbstract
 Objective: Consumption of Mitragyna speciosa (MS) leads to various toxicities including hepatotoxicity. Piper betle (PB) is a herb that possesses various therapeutic properties. The aim of the present study was to examine the protective effect of PB methanol extract (PBME) on MS-induced hepatotoxicity which could pave the way for any future antidote.
Methods: Twenty-four male Sprague–Dawley rats were randomized into control and experimental groups. The control group was further divided into the negative (G-T80) and positive (G-PB) control groups. The G-T80 group (n=6) received oral gavage of the vehicle, 15% Tween 80. The G-PB group (n=6) received PBME 200 mg/kg/day, orally. The experimental group was divided into two groups, i.e., The G-MS and G-MS (PB) groups. The G-MS group (n=6) received only MS methanol extract (MSME) 500 mg/kg/day, while the G-MS (PB) group (n=6) received MSME with concomitant treatment with PBME.
Results: Histopathology examination of the G-T80 and G-PB groups showed normal histology of the liver. The G-MS group showed liver injury features such as microvesicular steatosis, ballooning degeneration, acidophilic bodies, scattered focal necrosis, fibrous portal expansion, bridging fibrosis, sinusoidal congestion, and dilatation. These features were fewer in the G-MS (PB) group which received concomitant treatment with PBME.
Conclusion: Administration of PBME exerted a protective effect against MS-induced hepatotoxicity. Future clinical trials using PB as an antidote may help in combating MS-induced hepatoxicity.
Downloads
References
Raffa RB, editor. Kratom and Other Mitragynines: The Chemistry and Pharmacology of Opioids from a Non-Opium Source. London: CRC Press; 2014.
Ulbricht C, Costa D, Dao J, Isaac R, Le Blanc YC, Rhoades J, et al. An evidence-based systematic review of Kratom (Mitragyna speciosa) by the natural standard research collaboration. J Diet Suppl 2013;10:152-70.
Hassan Z, Muzaimi M, Navaratnam V, Yusoff NH, Suhaimi FW, Vadivelu R, et al. From kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neurosci Biobehav Rev 2013;37:138-51.
Zimmerman HJ. Hepatotoxicity: The Adverse Effects of Drugs and other Chemicals on the Liver. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.
Kapp FG, Maurer HH, Auwärter V, Winkelmann M, Hermanns- Clausen M. Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). J Med Toxicol 2011;7:227-31.
Dorman C, Wong M, Khan A. Cholestatic hepatitis from prolonged kratom use: A case report. Hepatology 2015;61:1086-7.
Harizal SN, Mansor SM, Hasnan J, Tharakan JK, Abdullah J. Acute toxicity study of the standardized methanolic extract of Mitragyna speciosa korth in rodent. J Ethnopharmacol 2010;131:404-9.
Kamal MS, Ghazali AR, Yahya NA, Wasiman MI, Ismail Z. Acute toxicity study of standardized Mitragyna speciosa korth aqueous extract in sprague-dawley rats. J Plant Stud 2012;1:120.
Sakaran R, Othman F, Jantan I, Thent ZC, Das S. Effect of subacute dose of Mitragyna speciosa korth crude extract in female sprague dawley rats. J Med Bioeng 2014;3:98-101.
Ilmie MU, Jaafar H, Mansor SM, Abdullah JM. Subchronic toxicity study of standardized methanolic extract of Mitragyna speciosa korth in sprague-dawley rats. Front Neurosci 2015;9:189.
Kumar N, Misra P, Dube A, Bhattacharya S, Dikshit M, Ranade S. Piper betle Linn. A maligned pan-asiatic plant with an array of pharmacological activities and prospects for drug discovery. Curr Sci 2010;99:922-33.
Pradhan D, Suri KA, Pradhan DK, Biswasroy P. Golden heart of the nature: Piper betle L. J Pharm Phytochem 2013;1:147-67.
Saravanan R, Prakasam A, Ramesh B, Pugalendi KV. Influence of Piper betle on hepatic marker enzymes and tissue antioxidant status in ethanol-treated wistar rats. J Med Food 2002;5:197-204.
Young SC, Wang CJ, Lin JJ, Peng PL, Hsu JL, Chou FP, et al. Protection effect of piper betel leaf extract against carbon tetrachloride-induced liver fibrosis in rats. Arch Toxicol 2007;81:45-55.
Pushpavalli G, Veeramani C, Pugalendi KV. Influence of Piper betle on hepatic marker enzymes and tissue antioxidant status in D-galactosamine-induced hepatotoxic rats. J Basic Clin Physiol Pharmacol 2008;19:131-50.
Milton Prabu S, Muthumani M, Shagirtha K. Protective effect of Piper betle leaf extract against cadmium-induced oxidative stress and hepatic dysfunction in rats. Saudi J Biol Sci 2012;19:229-39.
Greaves P. Histopathology of Preclinical Toxicity Studies: Interpretation and Relevance in Drug Safety Evaluation. London: Academic Press; 2011.
Anila R, Sathiya S, Babu CS, Rajkumar J. In vitro and in vivo protective effects of ambrex, a polyherbal formulation, against methotrexate induced damages in hepatic cells. Int J Pharm Pharm Sci 2015;7:164-70.
Al-Adhroey AH, Nor ZM, Al-Mekhlafi HM, Amran AA, Mahmud R. Antimalarial activity of methanolic leaf extract of Piper betle L. Molecules 2010;16:107-18.
Cotran RS, Kumar V, Collins T, Robbins SL. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia, PA: W.B. Saunders Company; 1999. p. 30-345.
Rathee JS, Patro BS, Mula S, Gamre S, Chattopadhyay S. Antioxidant activity of piper betel leaf extract and its constituents. J Agric Food Chem 2006;54:9046-54.
Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ, et al. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-76.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
